Last reviewed · How we verify
NCT03569605: IMPACT
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies
NA trial testing Self-help in Physical Activity in 280 participants. Completed in 29 January 2021.
29 January 2021
Quick facts
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 280 |
| Start date | 23 August 2018 |
| Primary completion | 29 January 2021 |
| Estimated completion | 29 January 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Self-help
- Intervention
Conditions studied
- Physical Activity — all drugs for Physical Activity →
- Neoplasms — all drugs for Neoplasms →
- Neoplasms by Site — all drugs for Neoplasms by Site →
- Cancer — all drugs for Cancer →
Sponsor
UNC Lineberger Comprehensive Cancer Center — full company profile →
Who can join
Adults 18 to 39, any sex, with Physical Activity or Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To date, few interventions have been designed specifically to promote physical activity in young adult cancer survivors, nor used novel technologies for delivery; none have been successful in promoting long-term adherence to PA. The purpose of this randomized controlled trial is to test the efficacy of a theory-based, mobile physical activity intervention with adaptive goal-setting and tailored feedback that is aimed at increasing physical activity among young adult cancer survivors.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial.
Valle CG, Diamond MA, Heiling HM, Deal AM, et al · · 2023 · cited 28× · PMID 36444676 · DOI 10.1002/cncr.34556 -
Recruitment of young adult cancer survivors into a randomized controlled trial of an mHealth physical activity intervention.
Valle CG, Camp LN, Diamond M, Nezami BT, et al · · 2022 · cited 16× · PMID 35379294 · DOI 10.1186/s13063-022-06148-5 -
Promoting physical activity in young adult cancer survivors using mHealth and adaptive tailored feedback strategies: Design of the Improving Physical Activity after Cancer Treatment (IMPACT) randomized controlled trial.
Valle CG, Pinto BM, LaRose JG, Diamond M, et al · · 2021 · cited 15× · PMID 33515784 · DOI 10.1016/j.cct.2021.106293 -
Physical activity maintenance among young adult cancer survivors in an mHealth intervention: Twelve-month outcomes from the IMPACT randomized controlled trial.
Valle CG, Diamond MA, Heiling HM, Deal AM, et al · · 2023 · cited 8× · PMID 37317660 · DOI 10.1002/cam4.6238 -
The usage of population and disease registries as pre-screening tools for clinical trials, a systematic review.
Foucher J, Azizi L, Öijerstedt L, Kläppe U, et al · · 2024 · cited 1× · PMID 38654383 · DOI 10.1186/s13643-024-02533-0 -
Disentangling Positive Affect Heterogeneity in a Digital Physical Activity Intervention for Young Adult Cancer Survivors: A Group-Based Multi-Trajectory Modeling Approach.
Choi SM, Willis EA, Smitherman AB, Martin SL, et al · · 2026 · PMID 42133893 · DOI 10.1002/pon.70484 -
Examining sociodemographic and health-related characteristics as moderators of an mHealth intervention on physical activity outcomes in young adult cancer survivors.
Valle CG, Heiling HM, Deal AM, Diamond MA, et al · · 2025 · PMID 38607515 · DOI 10.1007/s11764-024-01577-4
Verify or expand the search:
- PubMed search for NCT03569605
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Self-help
Trials testing the same drug.
- NCT04104724 — CFT Self-Help for Accessing Cervical Screening After Sexual Assault · NA · unknown
Other recruiting trials for Physical Activity
Currently open trials in the same condition.
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting
- NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students · NA · recruiting
- NCT07585409 — Physical Activity in Persons With Parkinson's Disease · recruiting
Other UNC Lineberger Comprehensive Cancer Center trials
Trials by the same sponsor.
- NCT06656936 — The PharmFIT Study · NA · not yet recruiting
- NCT05937659 — Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT · not yet recruiting
- NCT07479199 — Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors · not yet recruiting
- NCT07069595 — PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease · Phase 2 · recruiting
- NCT04266730 — Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03569605 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center
- Last refreshed: 1 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03569605.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing